Canada markets open in 2 hours 24 minutes

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.72+1.41 (+3.78%)
At close: 04:00PM EDT
38.72 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.65B
Enterprise Value 4.89B
Trailing P/E 114.71
Forward P/E 90.91
PEG Ratio (5 yr expected) 25.70
Price/Sales (ttm)7.17
Price/Book (mrq)19.06
Enterprise Value/Revenue 6.30
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.41
52-Week Change 3-8.42%
S&P500 52-Week Change 328.04%
52 Week High 354.44
52 Week Low 336.56
50-Day Moving Average 341.79
200-Day Moving Average 345.33

Share Statistics

Avg Vol (3 month) 31.08M
Avg Vol (10 day) 31.42M
Shares Outstanding 5145.96M
Implied Shares Outstanding 6145.96M
Float 8144.72M
% Held by Insiders 10.87%
% Held by Institutions 1100.54%
Shares Short (Apr 30, 2024) 48.75M
Short Ratio (Apr 30, 2024) 410.01
Short % of Float (Apr 30, 2024) 47.10%
Short % of Shares Outstanding (Apr 30, 2024) 46.00%
Shares Short (prior month Mar 28, 2024) 49.52M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -49.54%
Operating Margin (ttm)-125.12%

Management Effectiveness

Return on Assets (ttm)-8.13%
Return on Equity (ttm)-98.27%

Income Statement

Revenue (ttm)776.62M
Revenue Per Share (ttm)5.40
Quarterly Revenue Growth (yoy)-8.40%
Gross Profit (ttm)N/A
EBITDA -354.61M
Net Income Avi to Common (ttm)-384.77M
Diluted EPS (ttm)-2.67
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.21B
Total Cash Per Share (mrq)15.17
Total Debt (mrq)1.98B
Total Debt/Equity (mrq)667.43%
Current Ratio (mrq)7.37
Book Value Per Share (mrq)2.03

Cash Flow Statement

Operating Cash Flow (ttm)-323.46M
Levered Free Cash Flow (ttm)-156.68M